IgA Nephropathy Pipeline

iga-nephropathy-treatment-landscape

Jun 20, 2025

Advancements in IgA Nephropathy (IgAN) Treatment: From Standard-of-care (SoC) to Emerging Therapies

filspari-for-iga-nephropathy

Sep 16, 2024

Travere’s FILSPARI Approval Sparks Rivalry in the IgA Nephropathy Space

fabhalta-for-igan-treatment

Aug 19, 2024

Novartis’ FABHALTA: Leading the Way as the First Complement Inhibitor for IgAN

4-late-stage-iga-nephropathy-treatment-drugs

Jul 22, 2024

4 Late-Stage IgA Nephropathy Treatment Drugs to Look Out

iga-nephropathy-treatment-market-size-share-trends-growth-cagr-companies-analysis

Nov 05, 2021

IgA Nephropathy – Navigating the Emerging Therapies and Key Companies in the Therapeutics Domain

Toll-like Receptors Agonist
TLR 7 and 8 Agonist
Gene Therapies Whitepaper
Toll-like Receptors Agonist
TLR 7 and 8 Agonist
Gene Therapies Whitepaper

Newsletter/Whitepaper